All Posts: News Release

• BellRinger, Georgetown Lombardi Comprehensive Cancer Center’s Inaugural Bike Ride to End Cancer, Commences Saturday

  WASHINGTON (October 20, 2022) — BellRinger, a bike ride and community movement, will commence its inaugural 25-, 50, and 100-mile fundraising ride this Saturday, October 22, with an opening ceremony to kick off festivities on Friday, October 21. BellRinger has registered more than 800 riders with the goal to raise over $1.4 million. Local cancer […]

  Category: News Release Tags: BellRinger, cancer research, philanthropy

• The Society for Immunotherapy of Cancer (SITC) Publishes a Checklist to Maximize the Benefit to Patients for Clinical Trials in Immuno-oncology

  MILWAUKEE (October 6, 2022)— No uniform method has been established to predict the probability of success for individual clinical trials. To help identify clinical trials with a high likelihood of offering benefit to patients, the Society for Immunotherapy of Cancer (SITC) brought together a team of experts in immuno-oncology to create a conceptual framework for […]

  Category: News Release Tags: clinical trials, immunotherapy

• Long-term Study Supports Link Between Inflammation and Cognitive Problems in Older Breast Cancer Survivors

  Researchers followed hundreds of survivors for years to examine suspected source of worrying symptoms. LOS ANGELES (September 30, 2022) — Scientists are still trying to understand why many breast cancer survivors experience troubling cognitive problems for years after treatment. Inflammation is one possible culprit. A new long-term study of older breast cancer survivors, published today […]

  Category: News Release Tags: age and survivorship, breast cancer, cancer, cognitive effects of cancer treatment, survivorship

• Advanced Melanoma Survival Improves Significantly When Immunotherapy is Given Before Targeted Therapy

  The findings, coupled with results from another recent clinical trial, mark significant advances in the treatment of melanoma. WASHINGTON (September 27, 2022) — A clinical trial led by clinicians at Georgetown Lombardi Comprehensive Cancer Center showed a remarkable 20 percent advantage in the two-year overall survival rate for people with advanced melanoma who first received […]

  Category: News Release Tags: clinical trials, immunotherapy, melanoma

• Technique Developed in Mice Could Aid Detection of Cancer in Dense Breasts

  WASHINGTON (September 14, 2022) — A two-pronged approach to imaging breast density in mice, developed by researchers at Georgetown Lombardi Comprehensive Cancer Center, resulted in better detection of changes in breast tissue, including spotting early signs of cancer. The researchers hope that this approach will be translated from mice and improve breast imaging for people; […]

  Category: News Release Tags: breast cancer, breast density, breast imaging, student mentoring, student research

• Informing Children of a Mother’s Genetic Cancer Risk Does Not Impact Their Health Behaviors

  WASHINGTON (July 21, 2022) — Telling a child about their mother’s risk of hereditary breast and ovarian cancer does not adversely influence the offspring’s lifestyle or quality of life in the long term, according to a new study led by researchers at Georgetown Lombardi Comprehensive Cancer Center. The finding appeared July 21, 2022, in Pediatrics […]

  Category: News Release Tags: breast cancer, genetic counseling, genetic testing, ovarian cancer

• Georgetown Lombardi Comprehensive Cancer Center Launches BellRinger, Local Bike Ride to End Cancer

  Bike ride to raise millions to fund cancer research with inaugural October ride WASHINGTON (July 18, 2022) — Today, Georgetown Lombardi Comprehensive Cancer Center launched BellRinger, a bike ride and community movement to end cancer. BellRinger opened registration for its inaugural 25-, 50-, and 100- mile fundraising ride on Saturday, October 22, 2022 that will […]

  Category: News Release Tags: cancer research, philanthropy

• Intensive Telephone-Based Cessation Counseling Results in Improved Smoking Quit Rates

  WASHINGTON (July 12, 2022) — Offering intensive, weekly telephone-based cessation counseling along with nicotine replacement for people who smoke and who were undergoing screening for lung cancer resulted in over a twofold greater cigarette quit rate compared to people who received minimal counseling and nicotine replacement, according to results of a national, randomized trial conducted […]

  Category: News Release Tags: lung cancer, smoking, smoking cessation

• Biomarkers Found That Could Be Drug Targets Against a Deadly Form of Brain Cancer

  WASHINGTON (June 22, 2022) — Biomarkers that could be targets for novel drugs to treat glioblastoma brain tumors have been identified by investigators at Georgetown Lombardi Comprehensive Cancer Center, providing hope for a cancer that is highly lethal. Currently, the drug most often used to treat glioblastoma, temozolomide, is uniquely able to cross the blood/brain […]

  Category: News Release Tags: brain cancer, brain tumor, cancer research, glioblastoma

• Ralph Lauren Corporate Foundation Announces $25 Million Commitment to Five Cancer Centers Across America With Goal of Reducing Disparities in Cancer Care in Underserved Communities

  Commitment Recognized by White House Cancer Moonshot Georgetown University to establish The Ralph Lauren Center for Cancer Prevention at Georgetown Lombardi Comprehensive Cancer Center in Washington, D.C. Memorial Sloan Kettering (MSK) Ralph Lauren Center to build upon 20-year partnership serving Harlem, New York, and surrounding communities Conquer Cancer®, the ASCO Foundation, to collaborate on the […]

  Category: News Release Tags: breast cancer, cancer moonshot, cancer prevention, cancer research, CBCC, colon cancer, philanthropy, prostate cancer